dsm-firmenich has partnered with ExoLab Italia to bring the innovative, plant-derived exosomes technology to the global skin care market.
Plant-derived exosomes offer a multitude of benefits for personal care and beauty products and, ultimately, for skin health. They are packed with a powerful blend of antioxidants, vitamins, proteins, lipids and messenger molecules that work together to enhance skin health and combat signs of aging.
Gabriele Campi, CEO of ExoLab Italia, said, "By focusing on plant-derived exosomes, ExoLab Italia offers distinctive scientific proficiency in cellular health and skin recovery which, combined with dsm-firmenich's renowned expertise in skin biology, claim substantiation, and active ingredients, offers immense potential to elevate the standards of natural and effective skin care to unprecedented heights."
Emmanuel Butstraen, president perfumery and beauty, said, "I am delighted to welcome ExoLab Italia as a new partner to dsm-firmenich. Through this partnership with this pioneer in exosome treatment, we reaffirm our commitment to science as a central element to our innovation and product superiority."
Parand Salmassinia, president of personal care, perfumery and beauty, at dsm-firmenich, said, "We are thrilled to embark on this journey with ExoLab Italia. We truly believe that, together, we have the power to revolutionize the skincare market. This collaboration aligns perfectly with our commitment to providing our customers with the highest quality products that meet the growing demand for natural, effective and sustainable ingredients in the skin care market."